THE VARIABILITY OF VOLATILE ORGANIC COMPOUNDS IN CLINICAL ENVIRONMENTS

22 June 2021, Version 1

Abstract

The development of clinical breath-analysis is confounded by the variability of background volatile organic compounds (VOC). Interpretation of clinical breath-data at individual, and cohort levels requires characterisation of clinical-VOC levels and exposures. Active-sampling with thermal-desorption/gas chromatography-mass spectrometry recorded and evaluated VOC concentrations in 245 samples of indoor air from three sites in a large NHS provider trust in the UK over 27 months. 7344 clinical VOC were isolated and 328 VOC and 68 were observed in more than 5% and 30% of samples respectively; associated with exogenous and endogenous sources. 17 VOC were seasonal differentiators. Metabolites from the anaesthetic sevoflurane, and putative-disease biomarkers in room air indicated that exhaled VOC were a source of background-pollution in clinical breath-tests. Apart from solvents, and PPE-waxes, exhaled VOC concentrations above 3 µgm-3 are unlikely to arise from room air contamination. This level could be applied as a threshold for inclusion in studies.

Keywords

Breath-testing
Volatile organic compounds
Background-contamination
Thermal desorption gas chromatography-mass spectrometry
Exhaled biomarkers

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.